Ionis Pharmaceuticals Inc (NAS:IONS)
$ 35.91 -0.42 (-1.16%) Market Cap: 5.74 Bil Enterprise Value: 4.73 Bil PE Ratio: 0 PB Ratio: 8.65 GF Score: 40/100

Ionis Pharmaceuticals Inc Metagenomi Collaboration Webcast Transcript

Nov 14, 2022 / 01:00PM GMT
Release Date Price: $44.04 (+1.83%)
Operator

Good morning, and welcome to Ionis' Conference Call to discuss its collaboration with Metagenomi. (Operator Instructions) As a reminder, this call is being recorded.

At this time, I would like to turn the call over to Jennifer Capuzelo, Investor Relations, to lead off the call. Please begin.

Jennifer Capuzelo

Thank you, Joe. Hello, and thank you for joining us this morning for our discussion about our collaboration with Metagenomi.

Before we begin, I encourage everyone to review the press release Ionis issued this morning, which outlines the details of this agreement. We have also posted slides on our website that accompany today's call.

Joining me on today's call are Brett Monia, Chief Executive Officer; Frank Bennett, Chief Scientific Officer; and Eric Swayze, Executive Vice President of Research. And joining us for the Q&A portion of the call are Joseph Baroldi, Chief Business Officer; and Beth Hougen, Chief Financial Officer.

During this call, we will be making forward-looking statements that are based on our current

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot